Literature DB >> 27448488

Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Tsung-Chieh Jane Fu1, Joseph J Carter2, James P Hughes3, Qinghua Feng4, Stephen E Hawes1, Stephen M Schwartz1,2, Long Fu Xi5, Taylor Lasof6, Joshua E Stern7, Denise A Galloway2,8, Laura A Koutsky1, Rachel L Winer9.   

Abstract

To understand high-risk (hr) human papillomavirus (HPV) epidemiology in mid-adulthood, we assessed whether associations between incident detection of hrHPV DNA and recent sexual behavior differed according to whether or not there was serologic evidence of prior infection. From 2011 to 2012, we enrolled 409 women aged 30-50 years into a 6-month longitudinal study. We collected health and sexual behavior histories, enrollment sera for HPV antibody testing, and monthly self-collected vaginal swabs for HPV DNA genotyping. Generalized estimating equations logistic regression identified risk factors for type-specific incident hrHPV DNA, stratified by type-specific hrHPV serostatus at enrollment. Population attributable risks of hrHPV due to prior and recent exposure were estimated. When type-specific hrHPV serology was negative, recent sexual risk behavior was positively associated with incident hrHPV DNA (odds ratio in women reporting ≥3 recent sexual risk behaviors [e.g., new or multiple partners] vs. no recent sexual activity = 9.8, 95% CI: 2.4-40.6). No associations with recent sexual behavior were observed with positive type-specific hrHPV serology. Thirty percent of incident hrHPV DNA detection was attributable to prior infection (with positive serology) and 40% was attributable to recent sexual risk behavior (with negative serology). The proportion of incident hrHPV DNA detection attributable to recent sexual risk behavior decreased with increasing age. Among women with serologic evidence of prior infection, re-detection of the same hrHPV type is likely due to reactivation or intermittent detection of persistent infection. Without serologic evidence of prior infection, new detection is likely due to new acquisition or to intermittent detection of persisting infection.
© 2016 UICC.

Entities:  

Keywords:  human papillomavirus; incident; mid-adult; serology; women

Mesh:

Year:  2016        PMID: 27448488      PMCID: PMC5222584          DOI: 10.1002/ijc.30283

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Ayaka Hulbert; Mark Schiffman; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

Review 2.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

3.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

4.  Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Joseph J Carter; Ruchi Garg; Rachel L Winer; Qinghua Feng; Denise A Galloway; Laura A Koutsky
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

Review 5.  The known unknowns of HPV natural history.

Authors:  Patti E Gravitt
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

6.  Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.

Authors:  Anne F Rositch; Anne E Burke; Raphael P Viscidi; Michelle I Silver; Kathryn Chang; Patti E Gravitt
Journal:  Cancer Res       Date:  2012-09-27       Impact factor: 12.701

7.  Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.

Authors:  J J Carter; M M Madeleine; K Shera; S M Schwartz; K L Cushing-Haugen; G C Wipf; P Porter; J R Daling; J K McDougall; D A Galloway
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Obesity and human papillomavirus infection in perimenopausal women.

Authors:  Su-Hsun Liu; Anne F Rositch; Raphael P Viscidi; Michelle I Silver; Anne E Burke; Patti E Gravitt
Journal:  J Infect Dis       Date:  2013-07-09       Impact factor: 5.226

9.  Evidence and impact of human papillomavirus latency.

Authors:  Patti E Gravitt
Journal:  Open Virol J       Date:  2012-12-28

10.  Seroepidemiology of human polyomaviruses.

Authors:  Jaime M Kean; Suchitra Rao; Michael Wang; Robert L Garcea
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more
  16 in total

1.  Importance of Lifetime Sexual History on the Prevalence of Genital Human Papillomavirus (HPV) Among Unvaccinated Adults in the National Health and Nutrition Examination Surveys: Implications for Adult HPV Vaccination.

Authors:  Anne F Rositch; Eshan U Patel; Molly R Petersen; Thomas C Quinn; Patti E Gravitt; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

2.  Prevalence of genital HPV infection in STI and healthy populations and risk factors for viral persistence.

Authors:  Giulia Ciccarese; Astrid Herzum; Angela Pastorino; Marih Dezzana; Stefania Casazza; Maria Gabriella Mavilia; Francesco Copello; Aurora Parodi; Francesco Drago
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-16       Impact factor: 3.267

3.  Proportion of Incident Genital Human Papillomavirus Detections not Attributable to Transmission and Potentially Attributable to Latent Infections: Implications for Cervical Cancer Screening.

Authors:  Talía Malagón; Aaron MacCosham; Ann N Burchell; Mariam El-Zein; Pierre Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Clin Infect Dis       Date:  2022-08-31       Impact factor: 20.999

4.  Human Papillomavirus: The Equal Opportunity Pathogen.

Authors:  Patti E Gravitt
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 7.759

Review 5.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Authors:  Patti E Gravitt; Rachel L Winer
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

6.  Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women.

Authors:  George Valasoulis; Abraham Pouliakis; George Michail; Christine Kottaridi; Aris Spathis; Maria Kyrgiou; Evangelos Paraskevaidis; Alexandros Daponte
Journal:  Cancers (Basel)       Date:  2020-05-05       Impact factor: 6.639

7.  Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women.

Authors:  Eileen O Dareng; Sally N Adebamowo; Ayotunde Famooto; Oluwatoyosi Olawande; Michael K Odutola; Yinka Olaniyan; Richard A Offiong; Paul P Pharoah; Clement A Adebamowo
Journal:  BMC Infect Dis       Date:  2019-01-07       Impact factor: 3.090

Review 8.  Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Authors:  Eva H Clark; Robert H Gilman; Elizabeth Y Chiao; Patti E Gravitt
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

Review 9.  Mechanistic mathematical models: An underused platform for HPV research.

Authors:  Marc D Ryser; Patti E Gravitt; Evan R Myers
Journal:  Papillomavirus Res       Date:  2017-02-04

10.  Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior.

Authors:  Proma Paul; Anne Hammer; Anne F Rositch; Anne E Burke; Raphael P Viscidi; Michelle I Silver; Nicole Campos; Ada O Youk; Patti E Gravitt
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.